Pharmaceutical preparation of sacubitril valsartan sodium

A technology of sacubitril and pharmaceutical preparations, which is applied in the field of medicine and can solve the problems of reduced stability and easy moisture absorption of active ingredients

Active Publication Date: 2020-07-03
BEIJING WINSUNNY PHARMA CO LTD
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The sacubitril-valsartan sodium pharmaceutical preparation prepared by the present invention can well solve the problem that the active ingredient of sacubitril-valsartan sodium is easy to absorb

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical preparation of sacubitril valsartan sodium
  • Pharmaceutical preparation of sacubitril valsartan sodium
  • Pharmaceutical preparation of sacubitril valsartan sodium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027]

[0028] Preparation:

[0029] (1) Mix sacubitril-valsartan sodium, microcrystalline cellulose, dipotassium hydrogen phosphate, and sodium carboxymethyl starch evenly to prepare a mixture;

[0030] (2) dry granulating the mixture obtained in step (1) to obtain drug granules;

[0031] (3) Compress the drug granules into tablets.

Embodiment 2

[0033]

[0034] Preparation:

[0035] (1) Mix sacubitril-valsartan sodium, mannitol, pregelatinized starch, disodium hydrogen phosphate, and low-substituted hydroxypropyl cellulose evenly to prepare a mixture;

[0036] (2) dry granulating the mixture obtained in step (1) to obtain drug granules;

[0037] (3) Mix the drug granules and crospovidone evenly, and press into tablets.

Embodiment 3

[0039]

[0040] Preparation:

[0041] (1) Mix sacubitril-valsartan sodium, lactose, sorbitol, dipotassium hydrogen phosphate, disodium hydrogen phosphate, and croscarmellose sodium to prepare a mixture;

[0042] (2) dry granulating the mixture obtained in step (1) to obtain drug granules;

[0043] (3) Mix the drug granules with low-substituted hydroxypropyl cellulose evenly, and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical preparation of sacubitril valsartan sodium. The pharmaceutical preparation comprises sacubatril valsartan sodium, a diluent, a stabilizer and a disintegrant, wherein the stabilizer is one or two of dipotassium hydrogen phosphate and disodium hydrogen phosphate. Through the pharmaceutical preparation of sacubatril valsartan sodium, the problem that the activeingredient sacubatril valsartan sodium has easy absorption of moisture can be solved well, the smoothness of the preparation process of the preparation can be ensured, and no stability reduction of the pharmaceutical preparation is caused by the moisture absorption characteristic of the active ingredient.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical preparation of anti-heart failure drug sacubitril-valsartan sodium and a preparation method of the preparation. Background technique [0002] Heart failure is a life-threatening heart condition in which the heart cannot pump enough blood and is at high risk of death, repeated hospitalization and other symptoms (such as difficulty breathing, fatigue, fluid retention) that can seriously affect the patient longevity and quality of life. According to statistics, the number of cardiovascular disease patients in my country is at least 230 million, among which there are 4.2 million heart failure patients, accounting for about 18.67% of the global heart failure patients. At present, drug treatment is still an important means, and the main products in the standard treatment drug market are cardiotonic agents, diuretics and angiotensin-converting enzyme inhibitors. [0003] Sacub...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/41A61K31/216A61K9/20A61K47/02A61P9/04
CPCA61K9/2009A61K31/216A61K31/41A61P9/04A61K2300/00
Inventor 邹文娟傅远鹏耿玉先产运霞
Owner BEIJING WINSUNNY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap